UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $153.78 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 3.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,709,807 shares of the company's stock after buying an additional 50,440 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.85% of DocuSign worth $153,780,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in DOCU. UMB Bank n.a. raised its position in DocuSign by 1,654.7% during the 4th quarter. UMB Bank n.a. now owns 930 shares of the company's stock worth $84,000 after buying an additional 877 shares during the last quarter. Ballentine Partners LLC bought a new stake in shares of DocuSign during the fourth quarter valued at about $278,000. Perpetual Ltd bought a new stake in shares of DocuSign during the fourth quarter valued at about $297,000. Atomi Financial Group Inc. raised its stake in shares of DocuSign by 26.7% during the fourth quarter. Atomi Financial Group Inc. now owns 5,861 shares of the company's stock valued at $527,000 after purchasing an additional 1,235 shares in the last quarter. Finally, Nisa Investment Advisors LLC raised its stake in shares of DocuSign by 16.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 28,138 shares of the company's stock valued at $2,531,000 after purchasing an additional 3,935 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

DOCU has been the topic of several recent research reports. Jefferies Financial Group decreased their price target on shares of DocuSign from $115.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, March 31st. Royal Bank of Canada reissued a "sector perform" rating and set a $90.00 target price on shares of DocuSign in a research report on Friday, March 14th. Robert W. Baird set a $93.00 price objective on shares of DocuSign in a research report on Friday, March 14th. HSBC upgraded shares of DocuSign from a "reduce" rating to a "hold" rating and set a $70.00 price target for the company in a research note on Friday, April 11th. Finally, JPMorgan Chase & Co. raised shares of DocuSign from an "underweight" rating to a "neutral" rating and increased their price target for the company from $70.00 to $75.00 in a research note on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, DocuSign currently has an average rating of "Hold" and an average target price of $92.46.

Insiders Place Their Bets

In related news, CFO Blake Jeffrey Grayson sold 8,000 shares of the company's stock in a transaction on Tuesday, April 15th. The shares were sold at an average price of $76.09, for a total value of $608,720.00. Following the completion of the sale, the chief financial officer now owns 86,156 shares in the company, valued at $6,555,610.04. This represents a 8.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares in the company, valued at approximately $722,880.70. The trade was a 6.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 47,851 shares of company stock valued at $3,912,239 over the last ninety days. Company insiders own 1.01% of the company's stock.

DocuSign Trading Down 0.3%

DocuSign stock traded down $0.29 during mid-day trading on Thursday, hitting $85.54. The stock had a trading volume of 633,803 shares, compared to its average volume of 2,759,792. The firm's 50 day moving average is $81.72 and its 200 day moving average is $85.85. The firm has a market capitalization of $17.32 billion, a P/E ratio of 17.65, a P/E/G ratio of 6.94 and a beta of 1.21. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.84 by $0.02. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The business had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. During the same period in the prior year, the firm earned $0.76 EPS. The company's revenue for the quarter was up 9.0% compared to the same quarter last year. As a group, equities research analysts forecast that DocuSign, Inc. will post 1.17 earnings per share for the current year.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.